Navigation Links
Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Date:8/19/2007

convertible security - - - (12,215)

Investment and other income 482 294 797 417

Change in fair value of

derivative instruments (2,401) (56) 1,123 (7,620)

Interest expense (643) (573) (1,267) (1,140)

Total other (expense)

and income (2,562) (335) 653 (20,558)

Net (loss) income $(12,104) $(3,757) $(15,991) $(30,593)

Net (loss) income per

share, basic $(0.43) $(0.14) $(0.57) $(1.23)

Net (loss) income per

share, diluted $(0.43) $(0.14) $(0.60) $(1.23)

Weighted average shares

outstanding, basic 28,313,056 25,952,342 28,305,810 24,815,680

Weighted average shares

outstanding, diluted 28,313,056 25,952,342 28,403,507 24,815,680

EMISPHERE TECHNOLOGIES, INC.

Condensed Balance Sheets (Unaudited)

As of June 30, 2007 and December 31, 2006

(in thousands)

June 30, December 31,

2007 2006

Assets:

Cash, cash equivalents, restricted cash and

investments $8,939 $21,533

Accounts receivable 487 216

Prepaid expenses and other current assets 893 1,082

Total current assets 10,319 22,831

Equipment and leasehold improvements, net 2,247 2,652

Purchased technology, net 1,675 1,794

Other assets 798 815

Total A
'/>"/>

SOURCE Emisphere Technologies, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ia/--ChindexInternational,Inc.,("Chindex")(Nasdaq:...rn,healthcareproductsandservicesinthePeople,sRepub...the21stAnnualPiperJaffray,"Unplugged"HealthCareCon...ceHotel. , Managementiscurrentlyscheduledtopr...ne-on-onemeetingsthroughouttheday.Awebcast,ofthepr...
(Date:11/24/2009)...FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ...dDisclosureStatementtoday,November24,2009,withtheU....AhearingtoconsiderapprovaloftheDisclosureStatemen...ingontheconfirmationofthePlanscheduledforJanuary7,...sinfull.ThePlanisexpected,ifapproved,toallowholder...
(Date:11/24/2009)...re-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),...porttherapiestosave,supportandrestorefailinghearts...PiperJaffrayHealthCareConferenceonTuesday,December...effinancialofficer,willprovideanupdateonthecompany...PacificStandardTime). ,, Thepresentationwillbea...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 1Brown 26amp 3B Toland Supports Fight Against Hepatitis B 60447 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 1Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 2Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 4Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 5
... Myeloma Workshop held in,Kos, Greece demonstrates...th bortezomib, dexamethasone and lenalidomide plus...ry multiple,myeloma, and as a single agent in pati...lobulinemia, NEW YORK, June 29, 2007 /PRNewswire-F...announced that 4 posters were,presented at the 11t...
... vaccine has shown 90%,efficacy for prevention of ...d with the human papillomavirus (HPV) types target...published early Online,and in the upcoming issue o... or more,cases of cervical cancer worldwide, but t...ntribute to cervical cancer. , Professor Jorma Paa...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
(Date:11/26/2009)... , Benton Communications ...siness growth system for retailers struggling to m... (PRWEB) November 26, 2009 -- Flu fears is the t...les to the emergency room, according to Dr. David ...ewly released business growth system – The ...
(Date:11/25/2009)... ,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sen...esonanceImaging(MRI)coilsandsoftwareandCalgaryScie...ologies,haveintroducedawebversionofAegis(TM)Breast...iveinterfaceisthefirsttrulyzero-footprintWebclient...ntific,sPureWeb(TM)platformallowsforzero-footprint...
(Date:11/25/2009)... ,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayA...sfirst Winter Spare the Air Alert fo...facturedfirelogsoranyothersolidfuel,bothindoorsand...unhealthyairqualitytomorrow,"saidJackBroadbent,exe...esidentstorespectthehealthoftheirneighborsandfello...
(Date:11/25/2009)... , Does stress increase blood pressure? This sim...h for many years. New Stress-related gene Modulat... increase blood pressure? This simple question ha...s. Now new research has for the first time establ...the blood pressure response to stress in mice as w...
(Date:11/25/2009)... Survivors often plagued by neurological symptoms...ealthDay News) -- Neurological side effects are am...ivors of testicular cancer who were treated with c.... , The study included 1,409 Norwegian men trea...and 1994 who took part in a follow-up survey condu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...day,announced the first true single port laparosco...tem., At Baystate Medical Center, Springfield, MA...Surgery, performed a gallbladder removal procedure...eals. This provides unobstructed access to the cav...
...n and Adults With Dis...ream Corporation,today announced results of its 27...ser to benefit Easter Seals. Since the conclusion ...se dollars,were raised during the chain-wide ,Cone...
...y,(NYSE: LLY ) today announced that the European ...EO(R) (teriparatide [rDNA origin] injection) for t...ined, systemic,glucocorticoid therapy in women and... Human Use (CHMP) of the European,Medicines Evalua...
...ording Artist Chaka Khan, LOS ANGELES, April 3, 2...millionth visitor to BODY WORLDS today. This marks...eaking run for BODY WORLDS,at the California Scien...onsored by her foundation, were at the,exhibit whe...
...er the incidents , , THURSDAY, April 3 (He...tner violence suffer a wide range of physical and ...zation study that included 25,000 women in 11 coun...d Republic of Tanzania.,The study found that havin...
... to join Harvard University,s Ash Institute for De... the bi-annual conference,Frontiers of Innovation:...ridge March 31st through today. On Monday evening,... neglected,diseases and in disaster preparedness i...
Other Medicine News:Health News:SurgiQuest Announces First Procedure Using AirSeal(TM) Access System 2Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: